Effects of GLP-1 receptor agonists on mitochondrial function, inflammatory markers and leukocyte-endothelium interactions in type 2 diabetes-Reference-Cited by-同舟云学术

Effects of GLP-1 receptor agonists on mitochondrial function, inflammatory markers and leukocyte-endothelium interactions in type 2 diabetes

Published:2023-10 Issue: Volume:66 Page:102849
ISSN:2213-2317
Container-title:Redox Biology
language:en
Short-container-title:Redox Biology

Author:

Luna-Marco Clara,de Marañon Arantxa M.,Hermo-Argibay Alberto,Rodriguez-Hernandez Yohaly,Hermenejildo Jonathan,Fernandez-Reyes Meylin,Apostolova Nadezda,Vila Jose,Sola Eva,Morillas Carlos,Rovira-Llopis Susana,Rocha Milagros,Victor Victor M.^ORCID

Publisher

Elsevier BV

Subject

Organic Chemistry,Biochemistry,Clinical Biochemistry

Reference47 articles.

1. The Pathologic continuum of diabetic vascular disease;Orasanu;J. Am. Coll. Cardiol.,2009

2. Epidemiology of diabetes mellitus and cardiovascular disease;Glovaci;Curr. Cardiol. Rep.,2019

3. Human leukocyte/endothelial cell interactions and mitochondrial dysfunction in type 2 diabetic Patients and their association with silent myocardial ischemia;Hernandez-Mijares;Diabetes Care,2013

4. Type 2 diabetes as an inflammatory disease;Donath;Nat. Rev. Immunol.,2011

5. Targeting innate immune mediators in type 1 and type 2 diabetes;Donath;Nat. Rev. Immunol.,2019

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting organ-specific mitochondrial dysfunction to improve biological aging;Pharmacology & Therapeutics;2024-10

2. The role of glucagon-like peptide-1 receptor agonists (GLP1-RAs) in the management of the hypertensive patient with metabolic syndrome: a position paper from the Korean society of hypertension;Clinical Hypertension;2024-09-01

3. Effects of sodium-glucose cotransporter 2 inhibitors on cardiovascular and cerebrovascular diseases: a meta-analysis of controlled clinical trials;Frontiers in Endocrinology;2024-08-23

4. Update on Obesity and Cardiovascular Risk: From Pathophysiology to Clinical Management;Nutrients;2024-08-20

5. Intestinal glucagon-like peptide-1: A new player associated with impaired counterregulatory responses to hypoglycaemia in type 1 diabetic mice;World Journal of Diabetes;2024-08-15